A Targeted Metabolomics Approach for Clinical Diagnosis of Inborn Errors of Metabolism
Jacob, M.; Malkawi, A.; Albast, N., et al.
In an effort to improve biological interpretation in clinical research, Rahman and colleagues from King Faisal Specialist Hospital and Research Center developed a targeted LC-MS/MS metabolomics method to screen for a broad collection of inborn errors of metabolism (IEM) in rat and human tissues. The validated assay utilizes stable isotope standards and was demonstrated to be sensitive and robust in differential metabolic profiling of common IEMs.
Articles
- Lysine Propionylation Boosts Proteome Sequence Coverage and Enables a “Silent SILAC” Labeling Strategy for Relative Protein Quantification
- 13C-Labeled Yeast as Internal Standard for LC-MS/MS and LC High Resolution MS Based Amino Acid Quantification in Human Plasma
- Glutamine-Derived 2-Hydroxyglutarate Is Associated with Disease Progression in Plasma Cell Malignancies
- Hepatic Ketogenic Insufficiency Reprograms Hepatic Glycogen Metabolism and the Lipidome
- A Targeted Metabolomics Approach for Clinical Diagnosis of Inborn Errors of Metabolism
- A Guide to 13C Metabolic Flux Analysis for the Cancer Biologist
- SNMMI Image of the Year Is the Endocyte 177 Lu PSMA-617?
